| 2026-03-10 |
详情>>
内部人交易：
Bichara Guillermo等共交易5笔
|
| 2026-02-25 |
详情>>
股本变动：
变动后总股本46339.42万股
|
| 2026-02-25 |
详情>>
业绩披露：
2025年年报每股收益14.69美元,归母净利润68.98亿美元,同比去年增长5.07%
|
| 2026-02-05 |
财报披露：
美东时间 2026-02-05 盘前发布财报
|
| 2025-10-31 |
详情>>
业绩披露：
2025年三季报(累计)每股收益11.40美元,归母净利润53.68亿美元,同比去年增长10.91%
|
| 2025-08-01 |
详情>>
业绩披露：
2025年中报每股收益7.29美元,归母净利润34.39亿美元,同比去年增长4.53%
|
| 2025-05-01 |
详情>>
业绩披露：
2025年一季报每股收益3.53美元,归母净利润16.73亿美元,同比去年增长2.83%
|
| 2025-04-30 |
股东大会：
将于2025-07-29召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize, in a binding vote, the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under U.S. Securities and Exchange Commission rules.
4.To recommend, on an advisory and non-binding basis, the frequency of holding future advisory shareholder votes on the compensation of the Company’s named executed officers.
5.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
6.To consider and vote on a shareholder proposal requesting an annual report regarding the alignment of the Company’s direct and indirect lobbying activities with the Company’s 2050 climate neutrality ambition.
7.To conduct such other business as may properly come before the meeting.
|
| 2025-04-30 |
股东大会：
将于2025-07-29召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize, in a binding vote, the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under U.S. Securities and Exchange Commission rules.
4.To recommend, on an advisory and non-binding basis, the frequency of holding future advisory shareholder votes on the compensation of the Company’s named executed officers.
5.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
6.To consider and vote on a shareholder proposal requesting an annual report regarding the alignment of the Company’s direct and indirect lobbying activities with the Company’s 2050 climate neutrality ambition.
7.To conduct such other business as may properly come before the meeting.
|
| 2025-04-30 |
股东大会：
将于2025-07-29召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize, in a binding vote, the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under U.S. Securities and Exchange Commission rules.
4.To recommend, on an advisory and non-binding basis, the frequency of holding future advisory shareholder votes on the compensation of the Company’s named executed officers.
5.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
6.To consider and vote on a shareholder proposal requesting an annual report regarding the alignment of the Company’s direct and indirect lobbying activities with the Company’s 2050 climate neutrality ambition.
7.To conduct such other business as may properly come before the meeting.
|
| 2025-02-26 |
详情>>
业绩披露：
2022年年报每股收益8.30美元,归母净利润41.47亿美元,同比去年增长8.39%
|
| 2025-02-26 |
详情>>
业绩披露：
2024年年报每股收益13.71美元,归母净利润65.65亿美元,同比去年增长5.90%
|
| 2024-10-31 |
详情>>
业绩披露：
2023年三季报(累计)每股收益9.51美元,归母净利润46.56亿美元,同比去年增长65.16%
|
| 2024-10-31 |
详情>>
业绩披露：
2024年三季报(累计)每股收益10.09美元,归母净利润48.40亿美元,同比去年增长3.95%
|
| 2024-08-02 |
详情>>
业绩披露：
2024年中报每股收益6.84美元,归母净利润32.90亿美元,同比去年增长6.44%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益3.38美元,归母净利润16.27亿美元,同比去年增长7.32%
|
| 2024-04-29 |
股东大会：
将于2024-07-30召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize, in a binding vote, the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under U.S. Securities and Exchange Commission rules.
4.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
5.To conduct such other business as may properly come before the meeting.
|
| 2024-04-29 |
股东大会：
将于2024-07-30召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize, in a binding vote, the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under U.S. Securities and Exchange Commission rules.
4.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
5.To conduct such other business as may properly come before the meeting.
|
| 2024-04-29 |
股东大会：
将于2024-07-30召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize, in a binding vote, the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under U.S. Securities and Exchange Commission rules.
4.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
5.To conduct such other business as may properly come before the meeting.
|
| 2024-02-28 |
详情>>
业绩披露：
2023年年报每股收益12.70美元,归母净利润61.99亿美元,同比去年增长49.48%
|
| 2023-05-01 |
股东大会：
将于2023-07-24召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under applicable U.S. law and U.S. Securities and Exchange Commission rules.
4.To consider and vote on proposed amendments to Linde’s Memorandum and Articles of Association to reduce certain supermajority shareholder voting requirements.
5.To conduct such other business as may properly come before the meeting.
|
| 2023-05-01 |
股东大会：
将于2023-07-24召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under applicable U.S. law and U.S. Securities and Exchange Commission rules.
4.To consider and vote on proposed amendments to Linde’s Memorandum and Articles of Association to reduce certain supermajority shareholder voting requirements.
5.To conduct such other business as may properly come before the meeting.
|
| 2023-05-01 |
股东大会：
将于2023-07-24召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under applicable U.S. law and U.S. Securities and Exchange Commission rules.
4.To consider and vote on proposed amendments to Linde’s Memorandum and Articles of Association to reduce certain supermajority shareholder voting requirements.
5.To conduct such other business as may properly come before the meeting.
|
| 2022-12-09 |
股东大会：
将于2023-01-18召开股东大会
会议内容 ▼▲
- 1.To approve, subject to the approval by the requisite majorities at the Court Meeting, the scheme of arrangement that is included in the document of which this Notice forms a part, referred to as the “Scheme” or “Scheme of Arrangement,” whereupon and assuming the other conditions to the Scheme are satisfied, holders of Linde ordinary shares will receive, on a one-for-one basis, ordinary shares of a new publicly traded company incorporated in Ireland (“New Linde”), and that the directors of Linde be authorized to take all such action as they consider necessary or appropriate for carrying the Scheme into effect.
2.To approve, subject to the Scheme becoming effective, an amendment to the articles of association of Linde, which are part of the Linde constitution, referred to as the “Articles,” in respect of certain mechanics to effect the Scheme.
3.To approve the Common Draft Terms of Merger, whereupon and assuming the other conditions to the Merger are satisfied, Linde would be merged with and into New Linde, with New Linde surviving the merger.
|
| 2022-12-09 |
股东大会：
将于2023-01-18召开股东大会
会议内容 ▼▲
- 1.To approve, subject to the approval by the requisite majorities at the Court Meeting, the scheme of arrangement that is included in the document of which this Notice forms a part, referred to as the “Scheme” or “Scheme of Arrangement,” whereupon and assuming the other conditions to the Scheme are satisfied, holders of Linde ordinary shares will receive, on a one-for-one basis, ordinary shares of a new publicly traded company incorporated in Ireland (“New Linde”), and that the directors of Linde be authorized to take all such action as they consider necessary or appropriate for carrying the Scheme into effect.
2.To approve, subject to the Scheme becoming effective, an amendment to the articles of association of Linde, which are part of the Linde constitution, referred to as the “Articles,” in respect of certain mechanics to effect the Scheme.
3.To approve the Common Draft Terms of Merger, whereupon and assuming the other conditions to the Merger are satisfied, Linde would be merged with and into New Linde, with New Linde surviving the merger.
|
| 2022-12-09 |
股东大会：
将于2023-01-18召开股东大会
会议内容 ▼▲
- 1.To approve, subject to the approval by the requisite majorities at the Court Meeting, the scheme of arrangement that is included in the document of which this Notice forms a part, referred to as the “Scheme” or “Scheme of Arrangement,” whereupon and assuming the other conditions to the Scheme are satisfied, holders of Linde ordinary shares will receive, on a one-for-one basis, ordinary shares of a new publicly traded company incorporated in Ireland (“New Linde”), and that the directors of Linde be authorized to take all such action as they consider necessary or appropriate for carrying the Scheme into effect.
2.To approve, subject to the Scheme becoming effective, an amendment to the articles of association of Linde, which are part of the Linde constitution, referred to as the “Articles,” in respect of certain mechanics to effect the Scheme.
3.To approve the Common Draft Terms of Merger, whereupon and assuming the other conditions to the Merger are satisfied, Linde would be merged with and into New Linde, with New Linde surviving the merger.
|
| 2022-05-02 |
股东大会：
将于2022-07-25召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under applicable U.S. law and U.S. Securities and Exchange Commission rules.
4.To approve, on an advisory and non-binding basis, the Directors’ Remuneration Report (excluding the Directors’ Remuneration Policy) as set forth in the Company’s IFRS Annual Report for the financial year ended December 31, 2021, as required under Irish law
5.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
6.To consider and vote on a shareholder proposal regarding supermajority voting requirements in Linde’s Irish Constitution.
7.To conduct such other business as may properly come before the meeting.
|
| 2022-05-02 |
股东大会：
将于2022-07-25召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under applicable U.S. law and U.S. Securities and Exchange Commission rules.
4.To approve, on an advisory and non-binding basis, the Directors’ Remuneration Report (excluding the Directors’ Remuneration Policy) as set forth in the Company’s IFRS Annual Report for the financial year ended December 31, 2021, as required under Irish law
5.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
6.To consider and vote on a shareholder proposal regarding supermajority voting requirements in Linde’s Irish Constitution.
7.To conduct such other business as may properly come before the meeting.
|
| 2022-05-02 |
股东大会：
将于2022-07-25召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the ten director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, as required under applicable U.S. law and U.S. Securities and Exchange Commission rules.
4.To approve, on an advisory and non-binding basis, the Directors’ Remuneration Report (excluding the Directors’ Remuneration Policy) as set forth in the Company’s IFRS Annual Report for the financial year ended December 31, 2021, as required under Irish law
5.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
6.To consider and vote on a shareholder proposal regarding supermajority voting requirements in Linde’s Irish Constitution.
7.To conduct such other business as may properly come before the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-30 |
股东大会：
将于2021-07-26召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the twelve director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers as required under applicable U.S. law and U.S. Securities and Exchange Commission rules.
4.To approve, on an advisory and non-binding basis, a Directors’ Remuneration Policy as required under Irish law.
5.To approve, on an advisory and non-binding basis, the Directors’ Remuneration Report (excluding the Directors’ Remuneration Policy) as set forth in the Company’s IFRS Annual Report for the financial year ended December 31, 2020, as required under Irish law.
6.To approve the 2021 Linde plc Long Term Incentive Plan.
7.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
8.To conduct such other business as may properly come before the meeting.
|
| 2021-04-30 |
股东大会：
将于2021-07-26召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the twelve director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers as required under applicable U.S. law and U.S. Securities and Exchange Commission rules.
4.To approve, on an advisory and non-binding basis, a Directors’ Remuneration Policy as required under Irish law.
5.To approve, on an advisory and non-binding basis, the Directors’ Remuneration Report (excluding the Directors’ Remuneration Policy) as set forth in the Company’s IFRS Annual Report for the financial year ended December 31, 2020, as required under Irish law.
6.To approve the 2021 Linde plc Long Term Incentive Plan.
7.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
8.To conduct such other business as may properly come before the meeting.
|
| 2021-04-30 |
股东大会：
将于2021-07-26召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the twelve director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers as required under applicable U.S. law and U.S. Securities and Exchange Commission rules.
4.To approve, on an advisory and non-binding basis, a Directors’ Remuneration Policy as required under Irish law.
5.To approve, on an advisory and non-binding basis, the Directors’ Remuneration Report (excluding the Directors’ Remuneration Policy) as set forth in the Company’s IFRS Annual Report for the financial year ended December 31, 2020, as required under Irish law.
6.To approve the 2021 Linde plc Long Term Incentive Plan.
7.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
8.To conduct such other business as may properly come before the meeting.
|
| 2020-07-06 |
股东大会：
将于2020-07-27召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the twelve director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
4.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers.
5.To conduct such other business as may properly come before the meeting.
|
| 2020-07-06 |
股东大会：
将于2020-07-27召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the twelve director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
4.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers.
5.To conduct such other business as may properly come before the meeting.
|
| 2020-07-06 |
股东大会：
将于2020-07-27召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the twelve director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
4.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers.
5.To conduct such other business as may properly come before the meeting.
|
| 2020-04-27 |
除权日：
美东时间 2020-06-02 每股派息0.96美元
|
| 2019-04-30 |
股东大会：
将于2019-07-26召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the twelve director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
4.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers.
5.To recommend, on an advisory and non-binding basis, the frequency of holding future advisory shareholder votes on the compensation of the Company’s named executed officers.
6.To conduct such other business as may properly come before the meeting.
|
| 2019-04-30 |
股东大会：
将于2019-07-26召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the twelve director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
4.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers.
5.To recommend, on an advisory and non-binding basis, the frequency of holding future advisory shareholder votes on the compensation of the Company’s named executed officers.
6.To conduct such other business as may properly come before the meeting.
|
| 2019-04-30 |
股东大会：
将于2019-07-26召开股东大会
会议内容 ▼▲
- 1.By separate resolutions, to re-appoint the twelve director nominees described in the proxy statement.
2.To (a) ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers (“PwC”) as independent auditor of the Company and (b) to authorize the Board, acting through the Audit Committee, to determine PwC’s remuneration.
3.To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law.
4.To approve, on an advisory and non-binding basis, the compensation of the Company’s named executive officers.
5.To recommend, on an advisory and non-binding basis, the frequency of holding future advisory shareholder votes on the compensation of the Company’s named executed officers.
6.To conduct such other business as may properly come before the meeting.
|